CIMETIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Cimetidine patents expire, and what generic alternatives are available?
Cimetidine is a drug marketed by Apotex, Chartwell Molecules, Chartwell Rx, Contract Pharmacal, Cycle, Hikma, Ivax Sub Teva Pharms, L Perrigo Co, Mylan, Novitium Pharma, Perrigo, Pliva, Sandoz, Teva, Upsher Smith Labs, Watson Labs Inc, Watson Labs Teva, Cosette, Endo Operations, Hospira, Luitpold, Teva Parenteral, Ani Pharms, Chartwell Molecular, G And W Labs Inc, Pai Holdings Pharm, Pharm Assoc, and Pharmobedient Cnsltg. and is included in forty-nine NDAs.
The generic ingredient in CIMETIDINE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cimetidine
A generic version of CIMETIDINE was approved as cimetidine hydrochloride by PAI HOLDINGS PHARM on October 28th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIMETIDINE?
- What are the global sales for CIMETIDINE?
- What is Average Wholesale Price for CIMETIDINE?
Summary for CIMETIDINE
| US Patents: | 0 |
| Applicants: | 28 |
| NDAs: | 49 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 177 |
| Clinical Trials: | 65 |
| Patent Applications: | 4,105 |
| Drug Prices: | Drug price information for CIMETIDINE |
| DailyMed Link: | CIMETIDINE at DailyMed |
Recent Clinical Trials for CIMETIDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Washington | Phase 4 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 |
| Wollo University | Phase 4 |
Pharmacology for CIMETIDINE
| Drug Class | Histamine-2 Receptor Antagonist |
| Mechanism of Action | Histamine H2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for CIMETIDINE
Anatomical Therapeutic Chemical (ATC) Classes for CIMETIDINE
US Patents and Regulatory Information for CIMETIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Luitpold | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074353-001 | Dec 20, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pliva | CIMETIDINE | cimetidine | TABLET;ORAL | 074566-001 | Feb 27, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | CIMETIDINE | cimetidine | TABLET;ORAL | 074246-003 | May 17, 1994 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 074468-006 | Dec 29, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | CIMETIDINE | cimetidine | TABLET;ORAL | 074365-001 | Feb 28, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
